ÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×ÓÓëÒȵºËØÁªºÏ¾Ö²¿Ó¦ÓöÔÀÏÁäÌÇÄò²¡´óÊóÉÕÉË´´ÃæµÄ×÷Óáïÿ
Îâ ½¡1£¬Ñ¦Ïþ¶«2£¬Áõ¿¡Áá2£¬Ë¾Ð¡Ç¿2£¬Ñî¹ú»¢2£¬Áõ½¡ÔÆ2
¿ÎÌâ±³¾°£º¿ÎÌâ¾Éó²éºËʵ±»È·ÈÏΪÉϺ£ÊпÆÑ§¼¼Êõ³É¹û£¨µÇ¼ÇºÅ£º9312007Y1897£©¡£ÌåÄÚÍâʵÑéÒÑ֤ʵ´Æ¶þ´¼¿Éͨ¹ý³É¹Çϸ°ûµÄÅÔ·ÖÃÚÐźÅϵͳµ¼ÖÂÆÆ¹Çϸ°ûµòÍö£¬´Ó¶øÆðµ½ÒÖÖÆÆÆ¹Çϸ°ûÐÔ¹ÇÎüÊÕµÄ×÷Ó㬵«Æä¶Ô¹ÇÐγɵÄ×÷ÓÃÉв»Í³Ò»¡£ÿ
ͬÐÐÆÀ¼Û£ºÊµÑé̽ÌÖÁ˴ƶþ´¼ÔÚÌåÍâ¶Ô´óÊó³É¹Çϸ°ûµÄÓ°Ï죬½á¹û·¢ÏִƼ¤Ëؿɴٽø³É¹Çϸ°ûÔöÖ³£¬Ìá¸ß¼îÐÔÁ×Ëáø»îÐÔ£¬²¢´Ùʹ¹Ç¿ó»¯ÎïÖÊÔÚ¹ÇÄÚ³Á»ý£¬Õâ´Óϸ°ûˮƽ֤ʵÁ˴Ƽ¤ËØÔÚ¹ÇÐγÉÖеÄ×÷Óá£
ÖØÒªµÄ¸ÅÄ¢ÙÔ´úÅàÑøµÄϸ°û´¿ÂÊ£ºÖ¸¼îÐÔÁ×ËáøȾɫµÄϸ°ûÓëËùÓÐϸ°ûµÄ°Ù·Ö±È¡£Èç´¿ÂʵÍÓÚ90%£¬ËµÃ÷Ô´úÅàÑøµÄ³É¹Çϸ°ûÖк¬ÓÐÆäËûϸ°û½Ï¶à£¬½«Ó°ÏìʵÑéµÄ׼ȷÐÔ¡£¢Ú¿ó»¯½á½Ú£º¿ó»¯½á½ÚµÄÐγɴú±íÁ˳ɹÇϸ°ûÔöÖ³³ÉÊì²¢ÐÐʹ³É¹ÇµÄ¹¦ÄÜ¡£´Ù½ø¹Ç¿ó»¯µÄÖ÷Ҫϸ°ûÊdzɹÇϸ°û¡£Ã¿¸ö¿ó»¯½á½ÚΪ1¸ö¾ßÓÐÐγɽá½Ú¹¦ÄܵijɹÇϸ°û¾Ò»¶¨Ê±ÆÚµÄÔöÖ³¶øÐγÉ
1 À¼ÖÝ´óѧҽѧԺ£» 2¸ÊËàÊ¡ÈËÃñÒ½ÔºÉÕÉËÕûÐοµ¸´ÖÐÐÄ£¬¸ÊËàÊ¡À¼ÖÝÊÐ 730000
Îâ ½¡¡ï£¬ÄУ¬1969ÄêÉú£¬ºÓ±±Ê¡´ó³ÉÏØÈË£¬ºº×壬À¼ÖÝ´óѧҽѧԺÔÚ¶Á˶ʿ£¬Ö÷ÖÎҽʦ£¬Ö÷Òª´ÓÊ´´ÃæÐÞ¸´·½ÃæµÄÑо¿¡£
2005yjswj@163.com
ÕªÒª
Ä¿µÄ:ÎÄÏ×±¨µ¼µ¥Ò»¾Ö²¿Ó¦ÓÃÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×Ó»òÒȵºËضÔÌÇÄò²¡´´ÃæµÄÓúºÏ¾ßÓдٽø×÷Óá£ÄâÑéÖ¤¾Ö²¿ÁªºÏÓ¦ÓÃÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×ÓºÍÒȵºËضÔÀÏÁäÌÇÄò²¡´óÊóÉÕÉË´´ÃæÓúºÏµÄ×÷Óá£
·½·¨£ºÊµÑéÓÚ2006-10/2007-05ÔÚ¸ÊËàÊ¡ÖÐҽѧԺSPF¼¶¶¯ÎïʵÑéÊÒÍê³É¡£¢ÙʵÑé²ÄÁϼ°·Ö×飺SPF¼¶½¡¿µWistarÀÏÁä´óÊó88Ö»£¬ÄêÁä1ÄêÒÔÉÏ£¬´ÆÐÛ²»ÏÞ,ÌåÖÊÁ¿300~350 g¡£Ëæ»ú·ÖΪÌÌÉ˶ÔÕÕ×é20Ö»£¬ÌÇÄò²¡ÌÌÉ˶ÔÕÕ×é20Ö»£¬ÌÇÄò²¡ÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×Ó¶ÔÕÕ×é16Ö»£¬ÌÇÄò²¡ÒȵºËضÔÕÕ×é16Ö»£¬ÌÇÄò²¡ÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×Ó¡¢ÒȵºËØÖÎÁÆ×é16Ö»¡£ÊµÑéÓÃÓ㾫µ°°×пÒȵºËØÎªÉϺ£µÚÒ»Éú»¯Ò©ÒµÓÐÏÞ¹«Ë¾²úÆ·£»ÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×ÓÄý½º¼ÁΪ±±¾©½ðÈüʨÉúÎïÖÆÒ©¼¼Êõ¿ª·¢ÓÐÏÞ¹«Ë¾²úÆ·¡£¢ÚʵÑé¹ý³Ì£º³ýÌÌÉ˶ÔÕÕ×éÍ⣬ÆäËû×é´óÊóͨ¹ý¸ßÖ¬¡¢¸ßµ°°×¡¢¸ßÌÇËÇÑøºó¸¹Ç»×¢ÉäÁ´Äò×ô¾úËØ£¬½¨Á¢ÀÏÁä¢òÐÍÌÇÄò²¡¶¯ÎïÄ£ÐÍ£¬²¢ÒÔ¸ßÖ¬¡¢¸ßµ°°×¡¢¸ßÌÇËÇÑø¡£8Öܺó¸÷×鏸ÓèÉî¢ò¶ÈÌÌÉË¡£¢ÛʵÑéÆÀ¹À£ºÓÚÉ˺óµÚ1£¬3£¬7£¬14£¬21ÌìʱÏàµã²âÁ¿´´ÃæÃæ»ý£¬¼ÆËã´´ÃæÓúºÏÂÊ£»¹Û²ì×éÖ¯ÐÎ̬ѧ¡¢¼ì²â´´ÃæôǸ¬°±ËẬÁ¿£»²ÉÓÃÃâÒß×éÖ¯»¯Ñ§¼ì²âѪ¹ÜÄÚÆ¤Ï¸°ûÉú³¤Òò×Ó¡¢CD34µÄ±í´ï£»¼ÆËã΢Ѫ¹ÜÃܶȡ£ÊµÑé¹ý³Ì¶Ô¶¯ÎïµÄ´¦Àí·ûºÏ¶¯ÎïÂ×Àíѧ±ê×¼¡£
½á¹û£ºÓëÌÇÄò²¡ÌÌÉ˶ÔÕÕ×é¡¢ÌÇÄò²¡ÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×Ó¶ÔÕÕ×é¡¢ÌÇÄò²¡ÒȵºËضÔÕÕ×éÏà±È£¬ÌÇÄò²¡ÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×Ó¡¢ÒȵºËØÖÎÁÆ×éÀÏÁä´óÊó´´ÃæÓúºÏÂʼӿ죨P < 0.05£©£¬´´ÃæÉÏÆ¤»¯¼ÓËÙ£¬ôǸ¬°±ËẬÁ¿Ôö¼Ó£¨P < 0.05£©£¬Ñª¹ÜÄÚÆ¤Ï¸°ûÉú³¤Òò×Ó¡¢CD34ÑôÐÔ±í´ï£¬Î¢Ñª¹ÜÃܶÈÖµÔö¼Ó£¨P < 0.05£©¡£
½áÂÛ£º ¾Ö²¿ÁªºÏÓ¦ÓÃÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×ÓºÍÒȵºËØ¿Éͨ¹ýÐͬ×÷Óôٴ´Ã潺Եĺϳɣ¬Ôö¼Ó´´ÃæµÄѪ¹ÜÐγɣ¬¼ÓËÙÀÏÁäÐÔÌÇÄò²¡´óÊó´´ÃæÓúºÏ ¡£
¹Ø¼ü´Ê£ºÀÏÁäÌÇÄò²¡£»ÉÕÉË£»ÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×Ó£»ÒȵºËØ£»´´ÃæÓúºÏ
Î⽡£¬Ñ¦Ïþ¶«£¬Áõ¿¡Áᣬ˾Сǿ£¬Ñî¹ú»¢£¬Áõ½¡ÔÆ.ÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×ÓÓëÒȵºËØÁªºÏ¾Ö²¿Ó¦ÓöÔÀÏÁäÌÇÄò²¡´óÊóÉÕÉË´´ÃæµÄ×÷ÓÃ[J].Öйú×éÖ¯¹¤³ÌÑо¿ÓëÁÙ´²¿µ¸´£¬2008£¬12(11):2069-2073
[www.zglckf.com/zglckf/ejournal/upfiles/08-11/11k-2069(ps).pdf]
ÖÐͼ·ÖÀàºÅ:R587.1
ÎÄÏ×±êʶÂë:B
ÎÄÕ±àºÅ:1673-8225
(2008)11-02069-05
ÊÕ¸åÈÕÆÚ£º2007-08-26
ÐÞ»ØÈÕÆÚ£º2007-11-02
(07-50-8-4636/W¡¤A)
Influence of recombinant human platelet-derived growth factor plus insulin on burn wound healing in aging diabetic rats
Abstract
AIM:Reports have shown that local and simple application of recombinant human platelet-derived growth factor (rhPDGF) or insulin could promote wound healing in diabetes. This study evaluated the effect of the combination of rhPDGF and insulin on burn wound healing in type 2 diabetic aging rats.
METHODS: The experiment was performed at the SPF Animal Experimental Laboratory of Gansu College of Traditional Chinese Medicine from October 2006 to May 2007. ¢ÙEighty-eight aging SPF Wistar rats of more than one year old, either female or male and 300-350 g were selected and randomly divided into burn control group (n =20), diabetic burn group (n =20), diabetic rhPDGF control group (n =16), diabetic insulin control group (n =16) and diabetic rhPDGF and insulin therapy group (n =16). Protamine Zina insulin was the product of Shanghai No. 1 Biochem. & Pharma. Co., Ltd. and rhPDGF was provided by Beijing Golden Sets Biopharmaceutical Technology Co., Ltd. ¢ÚExcept for the burn control group, all aging rats were fed with high-fat, high-protein and high-sugar food, then intraperitoneally injected with streptozotocin (STZ) to establish animal model of type 2 diabetes. Then the rats were still feed with high-fat, high-protein, and high-sugar food. After eight weeks, the rats in each group were given man-made deep second-degree burn. ¢ÛThe wound area was measured in 1, 3, 7, 14, and 21 days after burn to calculate the rate of wound healing. Morphology and hydroxyproline (OHP) content were observed. The expression of vascular endothelial growth factor (VEGF) and CD34 were detected by immunohistochemical staining to calculate microvascular density (MVD). The experimental procedure was accorded with animal ethical standards.
RESULTS: Compared with diabetic burn group, diabetic rhPDGF control group, and diabetic insulin control group, the wound healing of aging rats in diabetic rhPDGF and insulin therapy groups was significantly faster (P < 0.05), the epithelization was accelerated; moreover, OHP content, the expression of VEGF, CD34, MVD in wound tissue were significantly increased (P < 0.05).
CONCLUSION: The combination of rhPDGF and insulin in local wound tissue can accelerate the wound healing in aging diabetic rats by promoting wound collagen synthesis and increasing wound vasifaction.
Wu J, Xue XD, Liu JL, Si XQ, Yang GH, Liu JY.Influence of recombinant human platelet-derived growth factor plus insulin on burn wound healing in aging diabetic rats.Zhongguo Zuzhi Gongcheng Yanjiu yu Linchuang Kangfu 2008;12(11):2069-2073(China) [www.zglckf.com/zglckf/ejournal/upfiles/08-11/11k-2069(ps).pdf]
0 ÒýÑÔ
ÀÏÁäÌÇÄò²¡ÉÕÉË´´ÃæÓÉÓÚ×ÔÉíµÄÌØµã£¬ÆäÓúºÏËÙ¶ÈÃ÷ÏÔµÍÓÚÒ»°ãÉÕÉË£¬Òò´Ë´Ù½øÀÏÁäÌÇÄò²¡ÉÕÉË´´ÃæÓúºÏ³ÉΪÖÎÁÆÉϵÄÒ»¸öÄѵ㡣»ùÒòÖØ×é¼¼ÊõµÄÎÊÊÀ,ΪʹÓÃÉú³¤Òò×ÓÖÎÁÆÀÏÁäÌÇÄò²¡´´ÃæÄÑÓúÌṩÁË¿ÉÄÜ¡£ÎÄÏ×±¨µÀµ¥Ò»¾Ö²¿Ó¦ÓÃÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×Ó»òÒȵºËضÔÌÇÄò²¡´´ÃæµÄÓúºÏ¾ßÓдٽø×÷ÓÃ,µ«ÁªºÏÓ¦ÓÃÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×ÓºÍÒȵºËضÔÀÏÁäÌÇÄò²¡ÉÕÉË´´ÃæµÄÓ°Ï챨µÀÉв»¶à¼û¡£ÀÏÁäÌÇÄò²¡ÉÕÉË´´ÃæÄÑÓúÓë×ÔÉíµÄÃâÒßµÍÏ£¬ÌÇ´úлÎÉÂÒ[1]£¬´´ÃæÓúºÏ¹ý³Ì½ºÔÐγɲ»Á¼£¬ÉÏÆ¤Ç¨ÒÆÑÓ³Ù¼°Ñ×Ö¢·´Ó¦Òì³££¬Ñª¹ÜÐγÉÄÜÁ¦¼õÍË£¬ÒÔ¼°Ï¸°ûÍâ»ùÖÊ¡¢Éú³¤Òò×ÓµÈÉúÎïѧÐÐΪ·¢Éú¸Ä±äÓйØ[2-5]¡£±¾ÊµÑé´ÓÑ×Ö¢·´Ó¦¡¢½ºÔºÏ³É¡¢ÐÂÉúѪ¹ÜµÄÐγɼ°Ðͬ×÷ÓõȽǶÈÀ´Ì½ÌÖÆä¿ÉÄܵÄ×÷ÓûúÖÆ¡£
1 ²ÄÁϺͷ½·¨
Éè¼Æ£ºËæ»ú¶ÔÕÕ¶¯ÎïʵÑé¡£
µ¥Î»£ºÀ¼ÖÝ´óѧҽѧԺºÍ¸ÊËàÊ¡ÈËÃñÒ½ÔºÉÕÉËÕûÐοµ¸´ÖÐÐÄ¡£
²ÄÁÏ£ºÊµÑéÓÚ2006-10/2007-05ÔÚ¸ÊËàÊ¡ÖÐҽѧԺSPF¼¶¶¯ÎïʵÑéÊÒ£¨BSL-4£©Íê³É¡£SPF¼¶½¡¿µWistarÀÏÁä´óÊó88Ö»(ÈÕÁä1ÄêÒÔÉÏ£¬ÓɸÊËàÊ¡ÖÐҽѧԺÊÔÑ鶯Îï·±ÓýÖÐÐÄÌṩ£¬Ðí¿ÉÖ¤ºÅ£ºSCXY2004-007)£¬´ÆÐÛ²»ÏÞ,ÌåÖÊÁ¿300~350 g¡£ÊµÑéÒÇÆ÷ºÍÊÔ¼Á£º¹âѧÏÔ΢¾µ£¨ÈÕ±¾£©£¬µçÈȺãÎÂˮԡÏ䣬¿ìËÙѪÌǼì²âÒÇ£¨ÃÀ¹úÇíÉ£©£¬Á´ëå×ô¾úËØ(ÃÀ¹úSigma¹«Ë¾)£»ÈéËáÄÆÁÖ¸ñ×¢ÉäÒ¹£¨¹ãÖÝ´óÚ£ÖÆÒ©ÓÐÏÞ¹«Ë¾£©£¬Ó㾫µ°°×пÒȵºËØ£¨ÉϺ£µÚÒ»Éú»¯Ò©ÒµÓÐÏÞ¹«Ë¾£¬ÅúºÅ051202£©£¬ÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×ÓÄý½º¼Á£¨±±¾©½ðÈüʨÉúÎïÖÆÒ©¼¼Êõ¿ª·¢ÓÐÏÞ¹«Ë¾£©£¬ôǸ¬°±ËᣨÄϾ©½¨³ÉÉúÎ﹤³ÌÑо¿Ëù£¬ÅúºÅ£º2007112£©ÊÔ¼ÁºÐ£¬¿¹CD34¿¹Ìå¡¢À±¸ùø±ê¼ÇÁ´Ã¹ÂѰ×ËØÃâÒß×éÖ¯»¯Ñ§È¾É«£¨SP£©ÊÔ¼ÁºÐ£¨Î人²©Ê¿µÂÉúÎ﹤³Ì¹«Ë¾£©£¬Ñª¹ÜÄÚÆ¤Ï¸°ûÉú³¤Òò×Ó¿¹Ì壨¸£ÖÝÂõÐÂÉúÎ﹤³Ì¹«Ë¾£©¡£
Éè¼Æ¡¢ÊµÊ©¡¢ÆÀ¹ÀÕߣºÊµÑéÉè¼ÆÕßΪµÚÒ»×÷Õߣ¬ÊµÑé¸ÉÔ¤ÕßΪȫ²¿×÷Õß¡£
¼¼Êõ·Ïߣº
ÀÏÁäÌÇÄò²¡¶¯ÎïÄ£Ðͺϲ¢ÌÌÉËÄ£ÐÍÖÆ×÷£º´óÊó88Ö»£¬²ÉÓÃËæ»úÊý×Ö·¨·Ö³É5×é, ΪÌÌÉ˶ÔÕÕ×é20Ö»£¬ÌÇÄò²¡ÌÌÉ˶ÔÕÕ×é20Ö»£¬ÌÇÄò²¡ÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×Ó¶ÔÕÕ×é16Ö»£¬ÌÇÄò²¡ÒȵºËضÔÕÕ×é16Ö»£¬ÌÇÄò²¡ÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×Ó¡¢ÒȵºËØÖÎÁÆ×é16Ö»¡£Ôìģǰ1¸öÔ£¬³ýÌÌÉ˶ÔÕÕ×éÍ⣬ÆäÓà¸÷×é´óÊóιÒÔ¸ßÖ¬¡¢¸ßµ°°×¡¢¸ßÌÇËÇÁÏ£¬ÒÔÓÕµ¼³öÒȵºËصֿ¹¡£¸ßÖ¬¡¢¸ßµ°°×¡¢¸ßÌÇÒûʳ1¸öÔºó£¬ÌÇÄò²¡Ä£ÐÍ×é½ûʳ²»½ûË®14 hºó¸¹Ç»×¢ÉäÁ´Äò×ô¾úËØ£¨ÈÜÓÚ0.1 mmol/LÄûÃÊËáÑλº³åÒºÖÐpH 4.5£¬ÐÂÏÊÅäÖÆ£©ÒÔ30 mg/kgÌåÖÊÁ¿£¬72 hºóβ¾²Âö²ÉѪ²â¶¨ÑªÌÇ¡£ÌÇÄò²¡¶¯ÎïÄ£ÐÍÔÚÓÕµ¼Ç°ºÍÓÕµ¼ºó¾ù¾Î²¾²Âö²ÉѪ,ÓÿìËÙѪÌÇÒDzâ»ù´¡ÑªÌǺÍËæ»úѪÌÇˮƽ¡£Í¬Ê±¶ÔÓÕµ¼ºó´óÊóµÄÌåÖÊÁ¿½øÐй۲ì,ÈôÓÕµ¼Ç°»ù´¡ÑªÌÇˮƽ< 8.9 mol/L,ÓÕµ¼ºóѪÌÇˮƽ> 16.7 mol/L£¬´óÊóÌåÖÊÁ¿Ã÷ÏÔϽµ£¬¼´¿ÉÊÓΪÌÇÄò²¡Ä£ÐÍÓÕµ¼³É¹¦[6]¡£·²²»´ï±êÕߣ¬3 dºó²¹×¢Á´Äò×ô¾úËØ£¨ÒÔ10~20 mg/kg¼ÁÁ¿¸¹Ç»×¢É䣩£¬²¢ÈÔιÒÔ¸ßÖ¬¡¢¸ßµ°°×¡¢¸ßÌÇËÇÁÏ8ÖÜ£¬Ã¿ÖܲâÌåÖÊÁ¿£¬ÑªÌÇ¡£ÀÏÁäÐÔÌÇÄò²¡´óÊóÄ£ÐÍÓÕµ¼³É¹¦ºó8ÖܽøÈëÉî¢ò¶ÈÌÌÉËÄ£ÐÍÖÆ×÷³ÌÐò£º¸÷×éÌÌÉËǰ24 h£¬¸øÓè25 g/LÎì°Í±ÈÍ×ÄÆ(35 mg/kgÌåÖÊÁ¿)¸¹Ç»×¢ÉäÂé×í£¬±³²¿ÓÃÁò»¯±µ»ìºÏÎïÍÑÈ¥±³²¿Ìå룬ÍÑëºó24 hÓõçÈȺãÎÂˮԡÏ䣬É趨ÖÂÉËζÈ80 ¡æ£¬Ê±¼ä15 s¡£Óè´óÊó±³²¿Ôì³ÉÔ¼Õ¼Ìå±í×ÜÃæ»ý(TBSA)10%µÄÉî¢ò¶ÈÌÌÉË,ͬʱ¸¹Ç»×¢Éä 10 mLÁÖ¸ñÊÏÒº¿¹ÐÝ¿Ë,·ÖÁýËÇÑø[7]¡£ÌÇÄò²¡ÌÌÉ˶ÔÕÕ×飬ÌÇÄò²¡ÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×Ó¶ÔÕÕ×飬ÌÇÄò²¡ÒȵºËضÔÕÕ×飬ÌÇÄò²¡ÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×Ó¡¢ÒȵºËØÖÎÁÆ×é´óÊóÊÔÑéÆÚ¼ä×ÔÓɽøÊ³¡¢ÒûË®,ÿÖܼà²âÌåÖÊÁ¿ºÍѪÌÇ¡£
¸øÒ©·½·¨Óë±ê±¾»ñÈ¡: ÓÚÌÌÉ˺󣬢ÙÌÇÄò²¡ÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×Ó¶ÔÕÕ×éÓÃ×¢ÉäÆ÷½«ÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×Ó°´ÊµÑéÉè¼Æ¼ÁÁ¿Îª7.0 ¦Ìg/cm2 ¾ùÔÈÍ¿ÓÚÏàÓ¦´´Ãæ[8]£¬ÎÞ¾úÉ´²¼°üÔú£¬»»Ò©1´Î/d£¬Ö±ÖÁÉË¿ÚÓúºÏ¡£¢ÚÌÇÄò²¡ÒȵºËضÔÕÕ×é´´ÃæÏ¾ֲ¿½þÈó×¢ÉäÒȵºËØ£¨ÓÃÃð¾úÉúÀíÑÎË®ÅäÖÆ³Éº¬Ó㾫µ°°×пÒȵºËØ0.1UµÄÈÜÒº 2 mL£©[9]£¬1´Î/d¡£¢ÛÌÇÄò²¡ÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×Ó¡¢ÒȵºËØÖÎÁÆ×éÏÈ´´ÃæÏ¾ֲ¿½þÈó×¢ÉäÒȵºËØ0.1 U 2 mLºóÓÃ×¢ÉäÆ÷½«ÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×Ó7.0 ¦Ìg/cm2¾ùÔÈÍ¿ÓÚ´´Ã棬1´Î/d¡£¢ÜͬʱÔÚÌÌÉ˺ó1£¬3£¬7£¬14£¬21 dÂé×íºó´¦ËÀ´óÊó£¬Ã¿×éÿʱÏàµã4Ö»£¬È¡´óÊó±³²¿È«²ãƤ·ô±ê±¾½øÐи÷Ïî¼ì²â¡£²¡Àí±ê±¾¹Ì¶¨ÓÚ40 g/L¼×È©ÈÜÒº£¬ÖƳÉʯÀ¯¿é±£´æ¡£ÊµÑé¹ý³ÌÖжԶ¯Îï´¦Ö÷ûºÏ¶¯ÎïÂ×Àíѧ±ê×¼¡£
´´ÃæÓúºÏ¹Û²ì£ºÓÚÉ˺óµÚ7£¬14£¬21ÌìÓÃ͸Ã÷·½¸ñÖ½Ãè»æ´´Ãæ¡£ÓüÆËã»úͼÏñ·ÖÎöÈí¼þ¼ÆËãÃæ»ý£¬¼ÆË㹫ʽ:´´ÃæÓúºÏÂÊ=£¨ÌÌÉËÃæ»ý£¸÷ʱÏàµãÃæ»ý£©/ÌÌÉËÃæ »ý¡Á100% ¡£×é֯ѧ¹Û²ì£º±ê±¾¹Ì¶¨ºó°´³£¹æÍÑË®¡¢°üÂñ¡¢ÇÐÆ¬, ËÕľ¾«-ÒÁºìȾɫ¹â¾µÏÂ¹Û²ì´´Ãæ×éÖ¯Ñ×Ö¢·´Ó¦£¬½ºÔ¸Ä±ä£¬´´ÃæÉÏÆ¤»¯µÈ±ä»¯¡£Æ¤·ô×éÖ¯ÖÐôǸ¬°±ËẬÁ¿¼ì²â:Ó¦ÓüîË®½â·¨²â¶¨ôǸ¬°±ËẬÁ¿£¬¾ßÌå°´ÊÔ¼ÁºÐ˵Ã÷½øÐвⶨ¡£Ê¹ÓÃѪ¹ÜÄÚÆ¤Ï¸°ûÉú³¤Òò×Ó¿¹Ìå¡¢Íÿ¹CD34¶à¿Ë¡¿¹ÌåºÍÀ±¸ùø±ê¼ÇÁ´Ã¹ÂѰ×ËØÃâÒß×éÖ¯»¯Ñ§È¾É«£¨SP£©ÊÔ¼ÁºÐ£¬°´À±¸ùø±ê¼ÇÁ´Ã¹ÂѰ×ËØÃâÒß×éÖ¯»¯Ñ§È¾É«£¨SP£©È¾É«·¨½øÐУ¬ÊµÑé²Ù×÷°´ÊÔ¼ÁºÐ˵Ã÷Êé½øÐУ¬Á×ËáÑλº³åÒº´úÌæÒ»¿¹×÷ÒõÐÔ¶ÔÕÕ,¹â¾µ¹Û²ì£¬½á¹ûÒÔ°û½¬»ò/ºÍ°ûºË×ÅרɫÕßΪÑôÐÔȾɫ¡£¿¹CD34¿¹Ìå¶Ô±ê±¾ÃâÒß×éÖ¯»¯Ñ§È¾É«£¬²Ù×÷²½Öè°´À±¸ùø±ê¼ÇÁ´Ã¹ÂѰ×ËØÃâÒß×éÖ¯»¯Ñ§È¾É«£¨SP£©ÊÔ¼ÁºÐ˵Ã÷Êé½øÐÐ,¸ù¾ÝCD34±í´ï²¢PareekµÈ[10]µÄ·½·¨¼ÆËã΢Ѫ¹ÜÃܶȡ£
Ö÷Òª¹Û²ìÖ¸±ê£º¢Ù¼ÆËã´´ÃæÓúºÏÂÊ¡£¢Ú´´Ãæ×éÖ¯Ñ×Ö¢·´Ó¦¡¢½ºÔ¸Ä±ä¡¢´´ÃæÉÏÆ¤»¯µÈ±ä»¯¡£¢Û¼ì²â¾Ö²¿×éÖ¯ÖÐôǸ¬°±ËẬÁ¿¡£¢Ü´´ÃæÑª¹ÜÄÚÆ¤Ï¸°ûÉú³¤Òò×ÓºÍCD34µÄ±í´ï¡£¢Ý΢Ѫ¹ÜÃܶȼÆÊý¡£
ͳ¼ÆÑ§·½·¨£ºÊý¾Ý¾ùÒÔ_x¡Às±íʾ¡£Óɱ¾ÎÄ×÷Õß²ÉÓÃSPSS 13.0Èí¼þ·ÖÎö£¬×é¼ä±È½Ï²ÉÓõ¥ÒòËØ·½²î·ÖÎö¡£
2 ½á¹û
2.1 ʵÑ鶯ÎïÊýÁ¿·ÖÎö ʵÑéÑ¡ÓôóÊó88Ö»£¬·ÖΪ5×飬ȫ²¿½øÈë½á¹û·ÖÎö¡£
2.2 ²»Í¬Ê±¼äµã¸÷×é´óÊó´´ÃæÓúºÏÂÊ ¼û±í1¡£
ÓëÌÇÄò²¡ÌÌÉ˶ÔÕÕ×飬ÌÇÄò²¡ÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×Ó¶ÔÕÕ×飬ÌÇÄò²¡ÒȵºËضÔÕÕ×éÏà±È£¬ÌÇÄò²¡ÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×Ó¡¢ÒȵºËØÖÎÁÆ×éÉ˺ó7£¬14£¬21 d´´ÃæÓúºÏÂÊÏÔÖøÔö¼Ó£¨P < 0.05£©£»ÓëÌÌÉ˶ÔÕÕ×éÏà±ÈÓÐÔö¼ÓµÄÇ÷ÊÆ¡£
2.3 ¸÷×é´óÊó´´Ãæ×é֯ѧ¹Û²ì½á¹û ¢ÙÌÌÉ˶ÔÕÕ×é1~ 3 dÕæÆ¤²ã¿É¼û´óÁ¿Ñ×ÐÔϸ°û½þÈ󣬽ºÔÏËά±äÐÔ»µËÀ£¬ÅÅÁÐÎÉÂÒ£¬ÕæÆ¤ÉÈÔ¼û²ÐÓàëÄÒº¹ÏÙ¡£É˺ó14 d¿É¼ûÉÏÆ¤Ï¸°û×Ô´´¿Ú±ßÔµ³¤Èë¡£¢ÚÓëÌÌÉ˶ÔÕÕ×éÏà±È, ÌÇÄò²¡ÌÌÉ˶ÔÕÕ×鯤·ô±¡,±íƤ²ã´ÎÉÙ,ÕæÆ¤½ºÔήËõ,°éÓдóÁ¿Ñ×ÐÔϸ°û½þÈó,É˺ó14 d¿É¼û¼«ÉÙÉÏÆ¤³¤È룬É˺ó21 dÈÔÓдóÁ¿»µËÀ×éÖ¯£¬´´ÃæÎ´Óú¡£¢ÛÌÇÄò²¡ÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×Ó¡¢ÒȵºËØÖÎÁÆ×éÉ˺ó3~7 d£¬Î¢Ñª¹ÜÀ©ÕÅ£¬´´¿Ú±ßÔµÒÑÓб¡µÄÉÏÆ¤³¤È룬Ѫ¹ÜÔöÉú¡¢ÈâÑ¿×éÖ¯Ðγɼ°ÉÏÆ¤Ï¸°ûÅÀÐгöÏÖµÄÔ磬É˺ó21 d£¬´´ÃæÉÏÆ¤ÍêÈ«ÉÏÆ¤»¯£¬ÉÏÆ¤Ï¸°û·Ö»¯½ÏºÃ£¬ÐÂÉú½ºÔ½Ï¶à¡£¢ÜÌÇÄò²¡ÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×Ó¶ÔÕÕ×é¡¢ÌÇÄò²¡ÒȵºËضÔÕÕ×éÉ˺ó14 d£¬¿É¼ûÉÏÆ¤Ï¸°û×Ô´´¿Ú±ßÔµ³¤Èë£¬ÕæÆ¤²ãÕæÆ¤½ºÔήËõ¼õÇᣬ»µËÀ×éÖ¯ÓëÕý³£×éÖ¯·Ö½ç½Ï³Ù£¬ÐÂÉú½ºÔ½Ï¶à¡£ÓëÌÇÄò²¡ÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×Ó¡¢ÒȵºËØÖÎÁÆ×éÏà±È£¬ÐÂÉúÉÏÆ¤Ï¸°ûÉú³¤ËÙ¶È»ºÂý£¬ÐÂÉú½ºÔÅÅÁÐÎÉÂÒ£¬É˺ó21 dÈÔÓÐÉÙÁ¿»µËÀ×éÖ¯£¬ÉÏÆ¤×éÖ¯ÐÞ¸´ÉÐδ½áÊø¡£ÌÇÄò²¡ÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×Ó¶ÔÕÕ×éºÍÌÇÄò²¡ÒȵºËضÔÕÕ×éÏà±È£¬´´ÃæÑ×Ö¢¼õÇᣬÈâÑ¿×éÖ¯ÐγɳöÏֽϳ١£¼ûͼ1¡£
2.4 ¸÷×é´óÊ󯤷ô×éÖ¯ÖÐôǸ¬°±ËẬÁ¿¼ì²â ¼û±í2¡£
2.5 ¸÷×é´óÊó´´ÃæÑª¹ÜÄÚÆ¤Ï¸°ûÉú³¤Òò×ÓºÍCD34µÄ±í´ï ¼ûͼ2£¬3¡£
2.6 ¸÷×é´óÊó΢Ѫ¹ÜÃܶȣ¨MVD£©¼ÆÊý ¼û±í3¡£

3 ÌÖÂÛ
´´Ãæ¾Ö²¿Ó¦ÓÃÒȵºËؿɳä·Ö·¢»ÓÆäҩЧ£¬¼õÉÙÓÃÁ¿ÒÔ¼°¶ÔÈ«Éí´úлµÄÓ°Ï죬µ«ÒȵºËصÄÉøÍ¸ÐÔ²»Ç¿£¬´´ÃæÏ½þÈó×¢Éä0.1 UÒȵºËز»»á¶ÔѪÌÇÔì³ÉÃ÷ÏÔµÄÓ°Ïì[9]¡£
±¾ÊµÑé¾Ö²¿ÁªºÏÓ¦ÓÃÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×ÓºÍÒȵºËغó£¬ÀÏÁäÌÇÄò²¡ÉÕÉË´´ÃæÉÏÆ¤Ï¸°ûÅÀÐгöÏÖµÄÔ磬´´ÃæÑ×Ö¢¼õ£¬ÈâÑ¿×éÖ¯ÐγÉÒàÔ磬ÓëÌÇÄò²¡ÌÌÉ˶ÔÕÕ×飬ÌÇÄò²¡ÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×Ó¶ÔÕÕ×飬ÌÇÄò²¡ÒȵºËضÔÕÕ×éÏà±È´´ÓúºÏÂÊÏÔÖøÔö¼Ó£¨P < 0.05£©£¬Ìáʾ¾Ö²¿ÁªºÏÓ¦ÓÃÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×ÓºÍÒȵºËØÄÜÃ÷ÏÔ´Ù½ø´´ÃæÓúºÏ¡£Æä×÷ÓûúÖÆ¿ÉÄÜΪ£ºÒȵºËØÍ¨¹ý½µµÍÑ×֢ǰϸ°ûÒò×Óˮƽ£¬Ôö¼ÓÉÕÉ˺ó¿¹Ñ×ϸ°ûÒò×Óˮƽ£¬´Ó¶ø»º½âÑ×Ö¢·´Ó¦¼°×èÖ¹¹ý¶ÈµÄÑ×Ö¢·´Ó¦, ²¢ÒÖÖÆÃâÒßϸ°ûÄÚµ°°×ÖʵĽµ½â,Ìá¸ßÃâÒß·´Ó¦µÄÖÊÁ¿[11]£»µ±×éÖ¯Êܵ½ËðÉËʱ£¬ÑªÐ¡°åÔ´ÐÔÉú³¤Òò×Ó±ã´Ó¦Á¿ÅÁ£ÖÐÊͷųöÀ´£¬µÍŨ¶ÈµÄѪС°åÔ´ÐÔÉú³¤Òò×Ó¶ÔÖÐÐÔÁ£Ï¸°û¡¢µ¥ºËϸ°û¡¢³ÉÏËάϸ°ûºÍƽ»¬¼¡Ï¸°ûµÈ²úÉúÇ÷»¯×÷Óã¬ÎüÒýÕâЩϸ°ûÏòËðÉ˲¿Î»Ç¨ÒÆ£¬Ò»·½ÃæÊ¹´´Ãæ¾Û¼¯ÁË´óÁ¿µÄÑ×ÐÔϸ°ûºÍ×éÖ¯ÐÞ¸´Ï¸°û£¬ÁíÒ»·½ÃæÓÖ¿É×÷ΪһÖÖÇ¿ÓÐÁ¦µÄѪ¹ÜÀ©ÕżÁʹ¾Ö²¿²úÉú³äѪ·´Ó¦£¬ÕâЩ¶¼ÊÇÓÐÀûÓÚ´Ù½ø´´¿ÚÐÞ¸´µÄÔçÆÚ²¡ÀíÉúÀí¹ý³Ì[12]¡£
´´ÃæÖеĽºÔÒ²ÊÇ´´ÃæÓúºÏµÄÒ»¸öÖ¸±ê£¬¶øôǸ¬°±ËáÔÚ½ºÔÖÐËùÕ¼±ÈÀýÏà¶Ôºã¶¨[13]£¬²â¶¨ôǸ¬°±ËẬÁ¿¿É¼ä½Ó·´Ó³½ºÔµÄº¬Á¿£¬¼ì²â½á¹ûÏÔʾ£ºÉ˺ó14£¬21 d£¬ÌÇÄò²¡ÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×Ó¡¢ÒȵºËØÖÎÁÆ×éÃ÷ÏÔ¸ßÓÚÌÇÄò²¡ÌÌÉ˶ÔÕÕ×飬ÌÇÄò²¡ÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×Ó¶ÔÕÕ×飬ÌÇÄò²¡ÒȵºËضÔÕÕ×飬±íÃ÷¾Ö²¿ÁªºÏÓ¦ÓÃÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×ÓºÍÒȵºËØÄÜÃ÷ÏÔ´Ù½ø´´Ã潺Եĺϳɡ¢¼ÓËÙϸ°ûÍâ»ùÖʵÄÖØ½¨¡£Æä×÷ÓûúÖÆ¿ÉÄÜΪ£ºÒȵºËØÄÜʹ³ÉÏËάϸ°û¹¦ÄÜ»îÔ¾£¬Ï¸°ûÖÜÆÚÌáǰ¼°´Ù½ø½ºÔ³Á»ý[8]£¬¼Ó¿ìÁË´´ÉËÓúºÏËÙ¶È[14]£»¾Ö²¿Ó¦ÓÃÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×Ó²»½ö´Ì¼¤³ÉÏËάϸ°ûÔöÖ³£¬¶øÇÒÓÕµ¼³ÉÏËάϸ°ûºÏ³É½ºÔÔö¼Ó£¬´Ó¶ø´Ù½ø´´ÃæÈâÑ¿×éÖ¯ÐγÉ[8]¡£
CD34ÊÇѪ¹ÜÐγɵÄÖØÒª±êÖ¾£¬ÐÂÉúѪ¹ÜµÄCD34³Ê¸ß±í´ï£¬¿¹CD34¿¹Ìå±ê¼ÇÄܺܺõØÇø·ÖÐÂÉúѪ¹ÜºÍ³ÉÊìѪ¹Ü[15]£¬¸ù¾ÝCD34±í´ï¼ÆËã³öµÄ΢Ѫ¹ÜÃܶÈÊÇÐÂÉúѪ¹ÜÐγɵÄÁ¿»¯Ö¸±ê¡£±¾ÊµÑéÖУ¬ÌÇÄò²¡ÌÌÉ˶ÔÕÕ×éÓëÌÌÉ˶ÔÕÕ×éÏà±È£¬´´ÃæÖеÄѪ¹ÜÄÚÆ¤Ï¸°ûÉú³¤Òò×Ó¡¢CD34µÄ±í´ï¼°Î¢Ñª¹ÜÃܶȽµµÍ£¬ÌáʾÀÏÁäÌÇÄò²¡ÉÕÉË´´ÃæÑª¹ÜÐγɲ»×㣬ÌÇÄò²¡ÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×Ó¡¢ÒȵºËØÖÎÁÆ×éÀÏÁä´óÊó¸÷ʱÏàµã´´Ãæ¾ùÏÔÖø¸ßÓÚÌÇÄò²¡ÌÌÉ˶ÔÕÕ×飬É˺ó21 dÏÔÖø¸ßÓÚÌÇÄò²¡ÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×Ó¶ÔÕÕ×飬ÌÇÄò²¡ÒȵºËضÔÕÕ×飬Ìáʾ¾Ö²¿ÁªºÏÓ¦ÓÃÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×ÓºÍÒȵºËؿɴٽøÀÏÁäÌÇÄò²¡ÉÕÉË´´ÃæÑª¹ÜÐγɣ¬Æä×÷ÓûúÖÆ¿ÉÄÜΪ£ºÒȵºËØ¿ÉÔö¼ÓÒ»Ñõ»¯µªµÄºÏ³ÉÓëÊÍ·Å£¬¶øÄÚÆ¤ÐÍÒ»Ñõ»¯µªÔÚѪ¹ÜÄÚÆ¤Éú³¤Òò×Ó´Ù½øÑª¹ÜÐγɹý³ÌÖз¢»ÓÖØÒª×÷ÓÃ,¶øÑª¹ÜÄÚÆ¤Ï¸°ûÉú³¤Òò×Ó¾ßÓÐÃ÷ÏԵĴٽøÑª¹ÜÐγÉ×÷ÓÃ[16]¡£¶øÉú³¤Òò×ÓÊÇ´Ùϸ°û·ÖÁѼÁ£¬¶Ôϸ°û¾ßÓÐÇ÷»¯×÷Ó㬵÷½Úϸ°û¼äµÄÏ໥×÷ÓÃ,Ó°Ïìϸ°ûÍâ»ùÖʵĺϳɺÍ×é·Ö£¬Ñª¹ÜÉú³ÉµÄÓÐÁ¦´Ì¼¤£¬ÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×ÓÄÜÃ÷ÏÔ´Ù½ø´´ÃæÓúºÏºÍÐÂÉúѪ¹ÜÐγɣ¬¿ÉÄÜÊÇÓÉÓÚѪС°åÔ´ÐÔÉú³¤Òò×Ó´Ù½øÄÚÆ¤Ç°Ìåϸ°û´óÁ¿Ôö¼ÓÐγɵÄ[17]¡£
±¾ÊµÑé½á¹û¾ù˵Ã÷¾Ö²¿ÁªºÏÓ¦ÓÃÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×ÓºÍÒȵºËؾßÓÐÁ¼ºÃµÄ´Ù½øÀÏÁäÌÇÄò²¡ÉÕÉË´´ÃæÓúºÏµÄ×÷Óã¬Æä×÷ÓûúÖÆ¿ÉÄÜΪ£ºÒȵºËؾßÓÐе÷Éú³¤Òò×ÓµÄ×÷ÓÃ[18]£¬¢ÙÒȵºËØ¿ÉÒÔÔö¼ÓÒȵºËØÑùÉú³¤Òò×Ó¢ñµÄˮƽ£¬´Ó¶øÔö¼ÓÆäÉúÎï¿ÉÀûÓÃÐÔ£¬¶øÒȵºËØÑùÉú³¤Òò×Ó¢ñÓëѪС°åÔ´ÐÔÉú³¤Òò×ÓÐͬ×÷ÓÃÄÜÔöÇ¿±íƤϸ°ûÔÙÉú[19]£¬¸üÓÐÀûÓÚ´´ÃæÓúºÏ¡£¢ÚÒȵºËØ¿ÉÔöÇ¿½ÇÖÊϸ°û·ÖÃÚ±íÆ¤Éú³¤Òò×ӺͲã𤵰°×µÄ¹¦ÄÜ[20]£¬¶ø±íƤÉú³¤Òò×ÓÓëѪС°åÔ´ÐÔÉú³¤Òò×ÓÐͬ×÷ÓüÓËÙÁË´´ÃæµÄÓúºÏ¡£
4 ²Î¿¼ÎÄÏ×
1 Fu XB£¬Cheng B.Chuangshang Waike Zazhi 2005;7(5):385-387
¸¶Ð¡±ø,³Ìì.ÖØÊÓÀÏÁ仯¶Ô´´ÃæÓúºÏÓ°ÏìµÄÑо¿[J].´´ÉËÍâ¿ÆÔÓÖ¾,2005,7(5):385-387
2 Lin Y,Wang RX,Nong QW,et al.Zhongguo Linchuang Kangfu 2005;9(3):118-120
ÁÖÔ´,ÍõÈóÐã,Å©ÇìÎÄ,µÈ.ÌÇÄò²¡´´ÃæÓúºÏ¹ý³ÌµÄ¶¯Ì¬×éÖ¯Ñ§ÌØÕ÷[J].ÖйúÁÙ´²¿µ¸´,2005,9(3):118-120
3 Gosain A,DiPietro LA. Aging and wound healing. World J Surg 2004;28: 321-326
4 Lerman OZ£¬Galiano RD£¬Armour M£¬et a1.Cellular dysfunction in the diabetic fibroblast impairm ent in migration£¬vascular endothelial growth factor production£¬and response to hypoxia. Am J Pathol 2003;162£º303-312
5 Lin WD,Lu SL,Qing C,et al.Zhonguo Linchuang Kangfu 2003; 18(6):370-372
ÁÖì¿¶°,½Ê÷Á¼,Çà´º,µÈ.ÌÇÄò²¡ÄÑÓú´´ÃæÓëÍíÆÚÌÇ»ù»¯ÖÕÄ©²úÎïµÄ¹ØÏµ[J].ÖйúÁÙ´²¿µ¸´ÔÓÖ¾,2003,18(6):370-372
6 Fang HH.Beijing£ºMilitary Medical Science Press 2002
·½ºñ»ª. ҽѧʵÑéÄ£ÐͶ¯Îï[M]. ±±¾©:¾üÊÂҽѧ¿ÆÑ§³ö°æÉç,2002
7 Feng SJ,Hua LN,Yan ZF,et al. Shanghai Dier Yike Daxue Xuebao 1995;15(3):195-196
·ëÊÀ½Ü,»¨À¼Å®,ÑÏÖÒð¥,µÈ.´óÊóÌÌÉËÄ£Ð͵ÄÖÆ×÷[J].ÉϺ£µÚ¶þÒ½¿Æ´óѧѧ±¨,1995,15(3):195-196
8 Sun TZ,Fu XB,Zhao ZL,et al.Zhongguo Weizhong Jijiu Yixue 2005; 15(10):596-599
ËïͬÖù,¸¶Ð¡±ø,ÕÔÖ¾Á¦,µÈ.ÖØ×éÈËѪС°åÔ´ÐÔÉú³¤Òò×ÓÄý½º¼Á´Ù½øÌÇÄò²¡´óÊó´´ÃæÓúºÏµÄʵÑéÑо¿[J].ÖйúÎ£ÖØ²¡¼±¾Èҽѧ£¬2005,15(10):596-599
9 Liu Y,Zhang X,Zhang Z. Zhonghua Shaoshang Zazhi 2004;20(2):98-101
Áõçü, ÕÂÐÛ, ÕÅÖ¾.¾Ö²¿Ó¦ÓÃÒȵºËضÔÌÌÉË´óÊó´´ÃæÓúºÏµÄÓ°Ïì[J].ÖлªÉÕÉËÔÓÖ¾,2004,20(2):98-101
10 Pareek G ,Shevchuk M,Armenakes NA,et al. The effect of finasteride on the expression of vascular endothelial growth factor and microvessel density:a possible mechanism for decreased prostatic bleeding in treated patients.J Urol 2003;169:20-23
11 Sundararajan VM,Vered S,Richard NM, et al. Influence of insulin therapy on burn wound healing in rats. J Surg Res 2003;109: 92-100
12 Zou ZT,Tan Q. Zhonghua Shaoshang Zazhi 2003,19(5):314-316
×ÞÖÒÌÒ,Ì·Ç«.ѪС°åÑÜ»¯Éú³¤Òò×ÓÓë´´ÃæÓúºÏ[J].ÖлªÉÕÉËÔÓÖ¾.2003,19(5):314-316
13 Niu YW,Lu SL,Xie T,et al.Shanghai Jiaotong Daxue Xuebao: Yixueban 2006;26(1):63-65
Å£éóö©,½Ê÷Á¼,лͦ,µÈ£¬ÌÇÄò²¡´óÊóÉî¢ò¶ÈÌÌÉË´´Ãæ³ÉÏËάϸ°ûÉúÎïѧÐÐΪµÄ¸Ä±ä,ÉϺ£½»Í¨´óѧѧ±¨:ҽѧ°æ,2006,26(1):63-65
14 Madibally SV,Solomon V,Mitchell RN,et a1.Influence of insulin therapy on burn wound healing in rats.J Surg Res 2003;109(2):92-100
15 Pareek G ,Shevchuk M, Armenakas NA,et al. The effect of finasteride on the expression of vascular endothelial growth factor and microvessel density: a possible mechanism for decreased prostatic bleeding in treated patients. J Urol 2003;169:20-23
16 Papapetropoulos A,Carcia Cardena G, Madri JA,et al. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.J Clin Invest 1997;100:3131-3139
17 Keseani SC,Katz AB,Lin FY,et a1.Adenoviral mediated gene transfer of PDGF-B enhances wound heding in type I and type II diabetic wounds.Wound Repair Regen 2004;12(5):497-504
18 Xie XF,Jia CY.Zhonghua Chuangshang Zazhi 2006;22(6):475-476
лÏþ·±,¼Ö³àÓî.ÒȵºËØÔÚÉÕÉË´´ÃæÓúºÏÖеÄ×÷ÓÃ[J].Öлª´´ÉËÔÓÖ¾,2006,22(6):475-476
19 Lu SL.Beijing: People's Military Medical Perss 2003
½Ê÷Á¼.ÉÕÉË´´ÃæÓúºÏ»úÖÆÓëм¼Êõ[M].2°æ.±±¾©:ÈËÃñ¾üÒ½³ö°æÉç,2003
20 Zhang X,Liu Y,Zhang Z,et al.Shanghai Dier Yike Daxue Xuebao 2005;25(8):812-814
ÕÂÐÛ,Áõçü,ÕÅÖ¾,µÈ. ÒȵºËØ¶Ô±íÆ¤½ÇÖÊÐγÉϸ°ûµÄ×÷ÓÃ[J].ÉϺ£µÚ¶þÒ½¿Æ´óѧѧ±¨,2005,25(8):812-814
|